- GUH - Phase II Study to Evaluate the Efficacy of Intensity Modulated Radiation Therapy with Hypofractionated Radiosurgical Boosts in the Treatment of Clinically Localized Prostate Cancer
- GUH - CALGB 70807 The Mens Eating and Living (MEAL) Study. A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
- GWU - Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients with High Risk localized Prostate Cancer
- GWU - A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy
- INOVA - A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
- INOVA - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
- JHMI - J1192 A Randomized Controlled Trial of ProstAtak as Adjuvant to Up-Front Radiation Therapy for Localized Prostate Cancer
- JHMI - J1207 Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol and daily genistein (G-2535) versus placebo in men with early stage prostate cancer undergoing prostatectomy
- JHMI - J1265 A Neoadjuvant Immunologic Study of Androgen Deprivation Therapy Combined With a GM-CSF-secreting Allogeneic Prostate Cancer Vaccine and Low-dose Cyclophosphamide in Men With High-risk Localized Prostate Cancer Undergoing Radical Prostatectomy
- JHMI - J0859 Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer
- NCI 11-C-0098 Evaluation of Ferumoxytol enhanced MRI for the detection of lymph node involvement in CaP
- NCI 11-C-0158 MR Image Guided Focal Therapy in Prostate Cancer
- NCI 11-C-0247 A randomized phase II study of L-BLP25 in combination with standard androgen deprivation therapy and radiation therapy for newly diagnosed, high risk prostate cancer patients.
- NCI 13-C-0119 Evaluation of local response of CaP to irradiation using multiparametric MRI & MR guided biopsies
- NCI - A Phase II Trial of Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
- UMD - Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer
- UMD - A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
- UMD - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
- UMD - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer
- UMD - Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer. A Phase III Randomized Trial
- WHC - CALGB 70807 The Mens Eating and Living (MEAL) Study. A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
- WRNMMC - A Randomized Controlled Trial of ProstAtak as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
- WRNMMC - The Men's Eating and Living (MEAL) Study - A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
- WRNMMC - A Multicenter Clinical Study of the Sonablate 500 (Sonablate) for the Treatment of Locally Recurrent Prostate Cancer With HIFU
- WRNMMC - Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer